Sleep and sleep disorders in people with Parkinson's disease.


Journal

The Lancet. Neurology
ISSN: 1474-4465
Titre abrégé: Lancet Neurol
Pays: England
ID NLM: 101139309

Informations de publication

Date de publication:
25 Jun 2024
Historique:
received: 22 01 2024
revised: 02 04 2024
accepted: 16 04 2024
medline: 29 6 2024
pubmed: 29 6 2024
entrez: 28 6 2024
Statut: aheadofprint

Résumé

Sleep disorders are common in people with Parkinson's disease. These disorders, which increase in frequency throughout the course of the neurodegenerative disease and impair quality of life, include insomnia, excessive daytime sleepiness, circadian disorders, obstructive sleep apnoea, restless legs syndrome, and rapid eye movement (REM) sleep behaviour disorder. The causes of these sleep disorders are complex and multifactorial, including the degeneration of the neural structures that modulate sleep, the detrimental effect of some medications on sleep, the parkinsonian symptoms that interfere with mobility and comfort in bed, and comorbidities that disrupt sleep quality and quantity. The clinical evaluation of sleep disorders include both subjective (eg, questionnaires or diaries) and objective (eg, actigraphy or video polysomnography) assessments. The management of patients with Parkinson's disease and a sleep disorder is challenging and should be individualised. Treatment can include education aiming at changes in behaviour (ie, sleep hygiene), cognitive behavioural therapy, continuous dopaminergic stimulation at night, and specific medications. REM sleep behaviour disorder can occur several years before the onset of parkinsonism, suggesting that the implementation of trials of neuroprotective therapies should focus on people with this sleep disorder.

Identifiants

pubmed: 38942041
pii: S1474-4422(24)00170-4
doi: 10.1016/S1474-4422(24)00170-4
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.

Déclaration de conflit d'intérêts

Declaration of interests MLF received a grant from Region AURA (France) Research and Development and the Société Française de Recherche et Médecine du Sommeil. MLF received a payment honoraria for lectures from Elvie, and financial support for attending meetings from Sos Oygène and Odalys Santé. LMT participated in the board of the American Academy of Sleep Medicine, American Academy of Sleep Medicine Foundation, and American Board of Sleep Medicine. All other authors report no conflict of interests regarding the content of this Review.

Auteurs

Alex Iranzo (A)

Sleep Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain; IDIBAPS, Universitat de Barcelona, Barcelona, Spain; CIBERNED, Universitat de Barcelona, Barcelona, Spain. Electronic address: airanzo@clinic.cat.

Valerie Cochen De Cock (V)

Sleep and Neurology Department, Beau Soleil Clinic, Montpellier, France; EuroMov Digital Health in Motion, University of Montpellier, IMT Mines Ales, Montpellier, France.

María Livia Fantini (ML)

Neurophysiology Unit, Neurology Department, Université Clermont Auvergne, CNRS, Institut Pascal, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Laura Pérez-Carbonell (L)

Sleep Disorders Centre, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK.

Lynn Marie Trotti (LM)

Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA; Emory Sleep Center, Emory University School of Medicine, Atlanta, GA, USA.

Classifications MeSH